Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid

NCT00888446 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

NETWORK

Sponsor class

Conditions

Human Immunodeficiency Virus Infections
HIV Infections

Interventions

BIOLOGICAL: tgAAC09
BIOLOGICAL: tgAAC09
BIOLOGICAL: tgAAC09
OTHER: Formulation buffer

Sponsor

International AIDS Vaccine Initiative

Collaborators

[object Object]